Quaternary ammonium compounds

NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease

Retrieved on: 
Thursday, July 8, 2021
Branches of biology, Neuroscience, Quaternary ammonium compounds, Neurophysiology, Neuromuscular junction, Skeletal muscle, Acetylcholine, Neuromuscular disease

Aarhus University and The Ohio State University are world-leading institutions in neuromuscular disease research.

Key Points: 
  • Aarhus University and The Ohio State University are world-leading institutions in neuromuscular disease research.
  • The primary aim of this study is to discover whether patients with CMT have neuromuscular junction (NMJ) transmission deficits.
  • The hypothesis for the study is that if patients with CMT are found to have deficits in NMJ transmission, then the novel treatment approach being developed by NMD Pharma could potentially have beneficial clinical effects on neuromuscular performance in these patients.
  • NMD Pharma is developing first-in-class small molecule inhibitors of the muscle specific chloride ion channel, the ClC-1 ion channel.

NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease

Retrieved on: 
Thursday, July 8, 2021
Branches of biology, Neuroscience, Quaternary ammonium compounds, Neurophysiology, Neuromuscular junction, Skeletal muscle, Acetylcholine, Neuromuscular disease

Aarhus University and The Ohio State University are world-leading institutions in neuromuscular disease research.

Key Points: 
  • Aarhus University and The Ohio State University are world-leading institutions in neuromuscular disease research.
  • The primary aim of this study is to discover whether patients with CMT have neuromuscular junction (NMJ) transmission deficits.
  • The hypothesis for the study is that if patients with CMT are found to have deficits in NMJ transmission, then the novel treatment approach being developed by NMD Pharma could potentially have beneficial clinical effects on neuromuscular performance in these patients.
  • NMD Pharma is developing first-in-class small molecule inhibitors of the muscle specific chloride ion channel, the ClC-1 ion channel.

Global Choline Chloride Market (2021 to 2026) - Growth, Trends, COVID-19 Impact and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 22, 2021
Chemicals, Plastics, Manufacturing, Branches of biology, Quaternary ammonium compounds, Cholinergics, Primary alcohols, Chemical compounds, Choline, Lipotropic, Acetylcholine, Fatty liver disease, Neurotransmitter, Nutritional neuroscience

The main function of choline is to act as a lipotropic agent and prevent abnormal fatty infiltration in the liver (fatty liver syndrome).

Key Points: 
  • The main function of choline is to act as a lipotropic agent and prevent abnormal fatty infiltration in the liver (fatty liver syndrome).
  • Moreover, choline chloride also helps in the formation of an excitatory neurotransmitter-acetylcholine, which is accountable for the proper functioning of the nervous system.
  • Furthermore, the rising incidences of animal diseases have led to the increased use of choline chloride in animal feed in various regional markets.
  • Such a huge market size underscores the considerable market size of the animal feed additives market, which can be further linked to the bulky market demand for Choline Chloride in the country.

Worldwide Dimethylaminopropylamine (DMAPA) Industry to 2026 - Growing Demand Owing to its Wide Range of Applications - ResearchAndMarkets.com

Retrieved on: 
Friday, May 14, 2021
Chemicals, Plastics, Manufacturing, Chemistry, Physical sciences, Chemical compounds, Diamines, Quaternary ammonium compounds, Dimethylaminopropylamine, Fatty acid amides, Antiseptics, Cocamidopropyl betaine, Hairdressing, Shampoo, Surfactant

b'Dimethylaminopropylamine (DMAPA) is a diamine that is widely used during the manufacturing of some surfactants, such as Cocamidopropyl betaine which is an ingredient in many personal care products including soaps, shampoos, and cosmetics and other personal care products.\nDMAPA is completely miscible with water, alcohols, esters, and ketones.

Key Points: 
  • b'Dimethylaminopropylamine (DMAPA) is a diamine that is widely used during the manufacturing of some surfactants, such as Cocamidopropyl betaine which is an ingredient in many personal care products including soaps, shampoos, and cosmetics and other personal care products.\nDMAPA is completely miscible with water, alcohols, esters, and ketones.
  • It has limited miscibility with diethyl ether, benzene, and chlorinated hydrocarbons.\nDMAPA is mild, skin-friendly, and hence its use has increased in the production of soft soap and shampoos as it does not cause irritation to the skin and eyes.\nThe global beauty industry is expected to compound annually at 5% to 7% to reach USD 800 billion by 2025.\nHence, owing to the growing application of Dimethylaminopropylamine (DMAPA) in beauty & personal care products especially in Asia-Pacific region, the demand for Dimethylaminopropylamine (DMAPA) is expected to increase over the forecast period.\nThe Asia-Pacific region is expected to dominate the market for Dimethylaminopropylamine (DMAPA) during the forecast period.
  • Due to the high demand from countries like China, India, and Japan, the market for Dimethylaminopropylamine (DMAPA) has been increasing in the region.\nThe largest producers of Dimethylaminopropylamine (DMAPA) are located in the Asia-Pacific region.
  • However, due to the outbreak of COVID-19, the demand for personal care products has been rapidly increasing which is expected to create market demand for DMAPA during the forecast period\nThe aforementioned factors, coupled with government support, are contributing to the increasing demand for Dimethylaminopropylamine (DMAPA) market during the forecast period.\n'

Nexus Pharmaceuticals Announces Launch of Succinylcholine Chloride Injection, USP

Retrieved on: 
Monday, April 12, 2021
Biotechnology, Pharmaceutical, Health, Medical Supplies, Chemical compounds, Drugs, Chlorides, Muscle relaxants, Quaternary ammonium compounds, Neuromuscular blockers, Suxamethonium chloride, Organ systems, Succinylcholine Chloride Injection, USP, Nexus Pharmaceuticals Inc.

b"Nexus Pharmaceuticals announced the launch of Succinylcholine Chloride Injection, USP in 200mg/10mL Multiple-Dose Vials.

Key Points: 
  • b"Nexus Pharmaceuticals announced the launch of Succinylcholine Chloride Injection, USP in 200mg/10mL Multiple-Dose Vials.
  • View the full release here: https://www.businesswire.com/news/home/20210412005426/en/\nNexus Pharmaceuticals Succinylcholine Chloride Injection, USP (Photo: Business Wire)\n\xe2\x80\x9cThe launch of Succinylcholine Chloride represents Nexus Pharmaceuticals\xe2\x80\x99 ability to supply critical products and to help fortify the supply chain,\xe2\x80\x9d said Shahid Ahmed, Chief Scientific Officer of Nexus Pharmaceuticals.
  • \xe2\x80\x9cThe COVID-19 pandemic deeply disrupted the supply of Succinylcholine Chloride, but Nexus\xe2\x80\x99 entry into the market will help alleviate constraints and provide peace of mind for our clinical partners.\xe2\x80\x9d\nNexus Pharmaceuticals\xe2\x80\x99 Succinylcholine Chloride Injection is available in cartons of 25 vials.\nSuccinylcholine Chloride Injection, USP is a sterile, nonpyrogenic solution to be used as an ultra-short-acting, depolarizing, skeletal muscle relaxant.
  • Nexus ensures that its high-quality FDA-approved drugs fulfill a critical unmet medical need and delivers dependable life-saving treatment options when and where they\xe2\x80\x99re needed most.

Insights on the Benzalkonium Chloride Global Market to 2030 - by Type, Application, End-use Industry and Geography

Retrieved on: 
Wednesday, March 31, 2021
Chemical compounds, Cationic surfactants, Quaternary ammonium compounds, Chemistry, Antiseptics, Chlorides, Benzyl compounds, Materials, Benzalkonium chloride, Polyvinyl chloride

DUBLIN, March 31, 2021 /PRNewswire/ -- The "Benzalkonium Chloride Market Research Report: By Type, Application, End-Use Industry - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 31, 2021 /PRNewswire/ -- The "Benzalkonium Chloride Market Research Report: By Type, Application, End-Use Industry - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • This is expected to be the key factor to take the global benzalkonium chloride market to $1,301.1 million by 2030 from $525.0 million in 2019, at a 9.6% CAGR between 2020 and 2030.
  • The benzalkonium chloride 50% bifurcation, under the type segment of the benzalkonium chloride market, held the larger share in the past.
  • The horticulture & household category is predicted to continue to dominate the benzalkonium chloride market throughout this decade, based on end-use industry.

Worldwide Benzalkonium Chloride Industry to 2030 - Market Analysis and Growth Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, March 26, 2021
Chemicals, Plastics, Manufacturing, Chemical compounds, Cationic surfactants, Quaternary ammonium compounds, Chemistry, Antiseptics, Chlorides, Benzyl compounds, Physical sciences, Benzalkonium chloride, Polyvinyl chloride

The "Benzalkonium Chloride Market Research Report: By Type, Application, End-Use Industry - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Benzalkonium Chloride Market Research Report: By Type, Application, End-Use Industry - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global benzalkonium chloride market to $1,301.1 million by 2030 from $525.0 million in 2019, at a 9.6% CAGR between 2020 and 2030.
  • The benzalkonium chloride 50% bifurcation, under the type segment of the benzalkonium chloride market, held the larger share in the past.
  • The horticulture & household category is predicted to continue to dominate the benzalkonium chloride market throughout this decade, based on end-use industry.

The Benzalkonium Chloride Market is projected to exceed $1.28 billion by 2027, Says Global Market Insights Inc.

Retrieved on: 
Monday, March 22, 2021
Biocides, Chemistry, Physical sciences, Bactericides, Antiseptics, Cationic surfactants, Quaternary ammonium compounds, Chlorides, Benzalkonium chloride, Disinfectant, Surfactant, Antimicrobial

Demand for antiseptics, disinfectants, wetting agent, solubilizing agent and antimicrobial preservative is expected to stimulate product demand from pharmaceutical sector.

Key Points: 
  • Demand for antiseptics, disinfectants, wetting agent, solubilizing agent and antimicrobial preservative is expected to stimulate product demand from pharmaceutical sector.
  • Benzalkonium chloride market from 50% concentration type surpassed USD 160 million in 2020 pertaining to its application as germicide and should raise product demand in the projected timespan.
  • The region is expected to witness increased benzalkonium chloride market demand for disinfectant application in agricultural process.
  • Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider.

Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021

Retrieved on: 
Thursday, February 18, 2021
Branches of biology, Muscarinic agonists, Quaternary ammonium compounds, Homeostasis, Physiology, Muscarine, Biology

Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, is scheduled to present on Thursday, February 25th, 2021 at 12:00 p.m. EST and will discuss the Company's progress and outlook.

Key Points: 
  • Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, is scheduled to present on Thursday, February 25th, 2021 at 12:00 p.m. EST and will discuss the Company's progress and outlook.
  • ANAVEX2-73 is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors.
  • Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimers disease.
  • Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.

Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday, February 11, 2021

Retrieved on: 
Monday, February 8, 2021
Branches of biology, Neuroscience, Muscarinic agonists, Communication, Forward-looking statement, Quaternary ammonium compounds, Physiology, Neurochemistry, Muscarine, Muscarinic acetylcholine receptor

Management will host a conference call on Thursday, February 11, 2021 at 4:30 pm Eastern Time to review financial results and provide an update on its clinical programs and corporate highlights.

Key Points: 
  • Management will host a conference call on Thursday, February 11, 2021 at 4:30 pm Eastern Time to review financial results and provide an update on its clinical programs and corporate highlights.
  • ANAVEX2-73 is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors.
  • These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties.
  • Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.